Stay updated on Vibegron in Women with Irritable Bowel Syndrome Clinical Trial
Sign up to get notified when there's something new on the Vibegron in Women with Irritable Bowel Syndrome Clinical Trial page.

Latest updates to the Vibegron in Women with Irritable Bowel Syndrome Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe NIH transition announcement banner about terminology and related updates is no longer displayed above the site navigation.SummaryDifference1%

- Check16 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check23 days agoChange DetectedA site-wide banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.SummaryDifference1%

- Check30 days agoChange DetectedThe site footer revision changed from v3.7.1 to v3.7.2 while the page continued to display a 403 error.SummaryDifference0.2%

- Check37 days agoChange DetectedThe footer’s revision indicator changed from v3.7.0 to v3.7.1; the study record is still not displayed.SummaryDifference0.2%

- Check58 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the previous content with an access-denied screen; users can no longer view the trial’s official title, summary, locations, or related details.SummaryDifference18%

Stay in the know with updates to Vibegron in Women with Irritable Bowel Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vibegron in Women with Irritable Bowel Syndrome Clinical Trial page.